Kabra Drugs Ltd — Board Meeting, 30-05-2025: Board Meeting

Kabra Drugs Limited has announced a board meeting on the financial results for the quarter and half-year. The company reported total income of Rs. 64.02 lakh, primarily from other income, with no revenue from operations. Employee benefits and other expenses rose significantly, resulting in a loss before tax of Rs. 108.51 lakh for the year. The net loss after tax stood at Rs. 108.56 lakh, despite a higher paid-up equity share capital of Rs. 23.71 Cr. Cash and cash equivalents surged to Rs. 21.30 Cr, fueled by proceeds from equity issuance. Anshu Chouhan & Associates have been appointed as the Secretarial Auditor for FY 2024-25. The audit report issued carried an unmodified opinion, reflecting no deviation in fund utilization.